Pharma's Almanac TV
API - Small Molecule
Cell and Gene Therapy
Oral Solid Dosage
Supply Chain Logistics
Company A to Z
By The Numbers
1566 Articles Available
Can't find what you're looking for? Try our
Biocept Expands its Pathology Partnership Offering for Liquid Biopsy with the Addition of Several Key Services
Scientists Clarify What Probiotics Are
Agenus Milestone Triggers $7.5M Payment from Gilead
Lilly Announces Final Results of Elanco Exchange Offer
XARELTO® Significantly Reduced Ischemic Stroke in Real-World Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulants
Fujifilm To Acquire Large-Scale Biologics Manufacturing Site From Biogen To Accelerate Growth Of Its Bio CDMO Business
Genomics Market Size Worth USD 27.6 Billion by 2025 | CAGR: 9.1%: Grand View Research, Inc.
Cell Based Assays Market is Projected to Collect Revenue of US$19,710.7 Million by 2022, Says TMR
The Global Human Microbiome Market is Expected to Reach US$ 1,197.08 Mn in 2025 from US$ 257.30 Mn in 2017
University of California Granted New CRISPR-Cas9 Patent, Extending its Patent Portfolio for Genome Editing
Lilly's CYRAMZA® Phase 3 RELAY Trial Met Primary Endpoint in First-Line Treatment of Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
Lipocine's LPCN 1144 for NASH Demonstrates Substantial Fatty Liver Resolution and Meaningful Liver Fat Reduction in NAFLD Population
Galmed Reports Positive Results From Pharmacokinetic Split Dose Study of Aramchol
ForteBio Introduces New Product for High-Throughput Glycan Screening
Theravance Biopharma Announces First Patient Dosed in Phase 2b/3 Study of TD-1473 in Patients with Ulcerative Colitis
Piramal Announces the Launch of Cinacalcet by its Partner, Slate Run Pharmaceuticals, in the U.S.
Long-Acting Injectable HIV Treatment Regimen of Rilpivirine and Cabotegravir Demonstrated Comparable Safety and Efficacy to Daily Oral HIV Therapy
Global Healthcare Robotics Market, 2023 - Market was Estimated at $5.40 billion in 2017 and is Anticipated to Reach $11.44 Billion by 2023
Statement from FDA Commissioner on Naming of Biological Medicines to Balance Competition and Safety for Patients Receiving These Products
FDA Releases Final Classification for Natural Cycles, the First and Only Birth Control App in the U.S.
Real World Evidence on Use of Halaven® (eribulin mesylate) Injection Following CDK 4/6 Inhibitor to be Presented at 36th Annual Miami Breast Cancer Conference
Lilly to Introduce Lower-Priced Insulin
FDA Approves New Nasal Spray Medication for Treatment-resistant Depression; Available Only at a Certified Doctor's Office or Clinic
Nasal Drug Delivery Systems Market Worth $67.99 Billion By 2025: Grand View Research, Inc.